Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
Cindy Franklin(University of Cologne), Selma Ugurel(Klinikum Bielefeld), Jochen Utikal(German Cancer Research Center), Dirk Debus(Nuremberg Hospital), Edgar Dippel(Klinikum Ludwigshafen), Rudolf Herbst(Helios Klinikum Erfurt), Ralf Gutzmer(University Hospitals of the Ruhr-University of Bochum), Susanne Horn(Vrije Universiteit Brussel), Michael Weichenthal(Christian-Albrechts-Universität zu Kiel), Sebastian Haferkamp(University Hospital Regensburg), Alexander Roesch(Essen University Hospital), Maike Trommer(University of Cologne), Andrea Forschner(University of Tübingen), Claudia Pfoehler(MSH Medical School Hamburg – University of Applied Sciences and Medical University), Kerstin Schatton(Heinrich Heine University Düsseldorf), Gerhard Weyandt(Bayreuth Medical Center), Dirk Schadendorf(National Center for Tumor Diseases), Iris Helfrich(German Cancer Research Center), Friedegund Meier(National Center for Tumor Diseases), Julia Welzel(University Hospital Augsburg), Elisabeth Livingstone(German Cancer Research Center), Peter J. Mohr(Roche (Switzerland)), Thilo Gambichler(Witten/Herdecke University), Frank Meiß(University of Freiburg), Marlene Garzarolli, Lisa Zimmer(The University of Sydney), Leonie Bluhm, Alexander Kreuter(HELIOS St. Elisabeth Klinik Oberhausen), Ulrike Leiter(University of Tübingen), Martin Kaatz(SRH Wald-Klinikum Gera), Lucie Heinzerling(Ludwig-Maximilians-Universität München), Michael Sachse(Klinikum Bremerhaven-Reinkenheide), Eren Celik(University of Cologne), Dorothée Nashan(Klinikum Dortmund), Jens Ulrich, Carsten Weishaupt(University Hospital Münster), Imke Grimmelmann(Medizinische Hochschule Hannover), Patrick Terheyden(University Hospital Schleswig-Holstein)
Cited by 19
Related Papers
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
|Arthritis & Rheumatism|1990|9.6k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k